Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Oct;38(4):914-25.
doi: 10.1002/jmri.24057. Epub 2013 Apr 1.

Effectiveness of MR angiography for the primary diagnosis of acute pulmonary embolism: clinical outcomes at 3 months and 1 year

Affiliations

Effectiveness of MR angiography for the primary diagnosis of acute pulmonary embolism: clinical outcomes at 3 months and 1 year

Mark L Schiebler et al. J Magn Reson Imaging. 2013 Oct.

Abstract

Purpose: To determine the effectiveness of MR angiography for pulmonary embolism (MRA-PE) in symptomatic patients.

Materials and methods: We retrospectively reviewed all patients whom were evaluated for possible pulmonary embolism (PE) using MRA-PE. A 3-month and 1-year from MRA-PE electronic medical record (EMR) review was performed. Evidence for venous thromboembolism (VTE) (or death from PE) within the year of follow-up was the outcome surrogate for this study.

Results: There were 190 MRA-PE exams performed with 97.4% (185/190) of diagnostic quality. There were 148 patients (120 F: 28 M) that had both a diagnostic MRA-PE exam and 1 complete year of EMR follow-up. There were 167 patients (137 F: 30 M) with 3 months or greater follow-up. We found 83% (139/167) and 81% (120/148) MRA-PE exams negative for PE at 3 months and 1 year, respectively. Positive exams for PE were seen in 14% (23/167). During the 1-year follow-up period, five patients (false negative) were diagnosed with DVT (5/148 = 3.4 %), and one of these patients also experienced a non-life-threatening PE. The negative predictive value (NPV) for MRA-PE was 97% (92-99; 95% CI) at 3 months and 96% (90-98; 95% CI) with 1 year of follow-up.

Conclusion: The NPV of MRA-PE, when used for the primary diagnosis of pulmonary embolism in symptomatic patients, were found to be similar to the published values for CTA-PE. In addition, the technical success rate and safety of MRA-PE were excellent.

Keywords: effectiveness, outcomes analysis; magnetic resonance angiography; negative predictive value; pulmonary embolism.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The spectrum of Pulmonary Embolism found at MRA. a: Coronal MRA of Right Interlobar artery (arrow) with peripheral perfusion abnormality (yellow arrows). b: Left lower lobe segmental embolus (white arrow) with small left pleural effusion (lightning bolt).
Figure 2
Figure 2
A 30-year-old female very dyspniec patient imaged with bilateral PE (white arrows): (a) First injection thick slab axial MIP reformation seen showed breathing artifact and the images are not diagnostic. (b) A repeat injection, performed while the same patient was still on the table, with second full MRA-PE (axial thick slab MIP).

References

    1. van Beek EJ, Kuijer PM, Buller HR, Brandjes DP, Bossuyt PM, ten Cate JW. The clinical course of patients with suspected pulmonary embolism. Arch Intern Med. 1997;157:2593–2598. - PubMed
    1. Silverstein MD, Heit JA, Mohr DN, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med. 1998;158:585–593. - PubMed
    1. Einstein AJ, Henzlova MJ, Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA. 2007;298:317–323. - PubMed
    1. Pijpe A, Andrieu N, Easton DF, et al. Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK) BMJ. 2012;345:e5660. - PMC - PubMed
    1. Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012;380:499–505. - PMC - PubMed

MeSH terms